En Es
Categories

Industry News

GE Healthcare and ESR Enter AI Partnership for ECR 2019

By Medimaging International staff writers
18 Oct 2018

Image: At ECR 2019, GE and the European Society of Radiology will offer joint sessions on artificial intelligence (AI) (Photo courtesy of GE Healthcare).GE Healthcare (Chicago, IL, USA) and the European Society of Radiology (Vienna, Austria) will be partnering on artificial intelligence (AI) for the upcoming European Congress of Radiology (ECR) to be held in Vienna, Austria on February 27-March 3, 2019. The partnership will include joint sessions on AI and a dedicated space at GE Healthcare’s booth where visitors will be able to experience the AI transformation through interactive tools.

On an average, hospital generates 50 petabytes of data every year, including clinical notes, lab tests, medical images, genomics, and more, although less than 3% of this data is utilized. AI holds the potential to make sense of the data and generate actionable insights to help improve provider efficiency, increase diagnostic accuracy, personalize treatment, improve patient experience, and enable remote and predictive maintenance. GE Healthcare has more than 200 imaging applications and is working with partners such as Nvidia, Microsoft, Amazon, and Intel to embed analytics, cloud capability, and AI into devices, workflows, and technologies that are already being used by healthcare providers.

“AI will be one of the leadings topics at next year’s ECR and this exclusive partnership with GE Healthcare is a major step in making ECR 2019 the leading event on AI for radiologists and related medical professionals. Through our joint efforts congress participants will be able to witness AI excellence on the highest level, making next year’s exhibition an event no one should miss,” said ESR President Professor Lorenzo E. Derchi from Genoa, Italy.

“We are honored to partner with the European Society of Radiology for the leading European radiology event. AI is one of the most exciting developments in healthcare today and a key enabler to achieve precision health. Done right, it can be the technology of the decade, perhaps the century, in healthcare. But there’s still much work to do, sound data science and eliminating data siloes are key. Europe and the European radiology community have a key role to play in the AI transformation,” said Catherine Estrampes, President and CEO of GE Healthcare Europe.



E-mail Print
FaceBook Twitter Google+ Linked in

GE Healthcare

GE Healthcare provides medical imaging and information technologies, medical diagnostics, patient monitoring systems, drug discovery, biopharmaceutical manufacturing technologies, performance improvement and performance solutions services. The company’s product areas include anesthesia delivery, diagnostic ECG, mammography, radiography, surgical imaging, maternal-infant care and clinical consumables.
More info

More articles about GE Healthcare

03 May 2019
First Deep Learning-Based Image Reconstruction Technology Receives FDA Clearance
GE Healthcare has received 510(k) clearance from the U.S. FDA for its Deep Learning Image Reconstruction (DLIR) engine on its new Revolution Apex CT device, and as an upgrade to its Revolution CT system in the U.S.
Read More
15 Oct 2018
GE Healthcare to Implement First AI-Powered Hospital Command Centers
GE Healthcare is collaborating with hospital service providers in Europe and the US for implementing an artificial intelligence (AI)-powered command center to effectively and efficiently synchronize all elements of a patient's hospital experience. The AI-powered system will support caregivers to enhance patient safety, orchestrate seamless care delivery and get patients back home sooner.
Read More
26 Jun 2018
GE to Spin Off Healthcare Business
In line with a sweeping strategic reorganization, General Electric Company has announced the decision to spin off its Healthcare business segment as an independent company. The move comes on the heels of a lengthy managerial review conducted by GE management under newly appointed CEO John Flannery.
Read More
16 Jan 2018
GE Healthcare and Roche Partner to Develop Digital Diagnostics Platform
GE Healthcare and Roche have entered into a strategic, long-term partnership to jointly develop and co-market digital clinical decision support solutions. Initially, the partnership will focus on products that accelerate and improve individualized treatment options for cancer and critical care patients.
Read More
06 Dec 2017
GE Healthcare and Nuance Partner with NVIDIA to Bring AI to Medical Imaging
Healthcare-solution providers GE Healthcare and Nuance Communications, Inc., have partnered with NVIDIA, a leader in visual computing technologies, for using the company’s deep learning platform to bring Artificial Intelligence (AI) to medical imaging.
Read More
05 Dec 2017
GE Launches Drawbridge Health to Transform Blood Collection
GE Healthcare has introduced Drawbridge Health, a privately held healthcare technology company, which is developing a people-friendly system to integrate draw, collection and stabilize blood samples into a single device. The technology which integrates engineering and proprietary chemistries is also being developed to support room temperature shipping and streamlined downstream processing, thus ensuring reliable, accurate results.
Read More
28 Nov 2017
Global Surgical Imaging Market to Reach USD 1.63 Billion by 2022
The global surgical imaging market is projected to grow at a CAGR of 5.5% from an estimated value of USD 1.25 billion in 2017 to USD 1.63 billion by 2022, driven mainly by the growing popularity of Flat Panel Detector C-arms (FPD C-arms) owing to the advantages of FPDs over image intensifiers, reimbursement cuts on analog radiography systems, and rising demand for minimally invasive procedures.
Read More
28 Nov 2017
GE Healthcare and DiA Imaging Analysis to Develop Machine Learning Algorithms
GE Healthcare has entered into a multi-year, non-exclusive licensing and professional services agreement with DiA Imaging Analysis, a medical imaging analysis software company, for developing automated imaging analysis technology to work with its ultrasound devices.
Read More

Additional news

06 Jul 2019
ACR Expands Pilot Program Focused on AI and Radiology
Radiology professionals from seven renowned health care institutions will use the ACR AI-LAB to demonstrate the process of creating investigational artificial intelligence (AI) models from image data without the use of a programming language.
Read More
06 Jul 2019
Konica Minolta Offers AI-Based Cardiac Ultrasound Analysis
Konica Minolta Healthcare Americas Inc, a provider of medical diagnostic imaging and healthcare information technology, has announced a partnership with DiA Imaging Analysis, a provider of artificial intelligence (AI) powered ultrasound analysis solutions.
Read More
06 Jul 2019
VR and AI Drive Exponential Growth in Integrated Operating Rooms
The operating room (OR) is transforming from a seemingly simple box into a technology-powered, infection-free, and sleek surgical environment.
Read More
06 Jul 2019
AI-Based Image Reconstruction Solution Receives FDA Clearance
Canon Medical Systems USA, Inc. has received 510(k) clearance from the FDA for its new deep convolutional neural network (DCNN) image reconstruction technology.
Read More
06 Jul 2019
Bracco Imaging Acquires Blue Earth Diagnostics to Expand Portfolio
Bracco Imaging S.p.A. has signed a definitive agreement to acquire Blue Earth Diagnostics, a molecular imaging company.
Read More
06 Jul 2019
AI Approach Lowers Radiation Exposure from CT Imaging
Engineers at the Rensselaer Polytechnic Institute worked along with radiologists at Massachusetts General Hospital and Harvard Medical School to demonstrate that machine learning has the potential to vastly advance medical imaging, particularly computerized tomography (CT) scanning, by reducing radiation exposure and improving image quality.
Read More
06 Jul 2019
New AI-based Method Detects Brain Response to MS Treatment
Researchers at University College London and King's College London have developed a new artificial intelligence (AI)-based method for detecting the brain's response to treatment in multiple sclerosis (MS).
Read More
06 Jul 2019
Global Molecular Diagnostics Market to Reach USD 13.87 Billion by 2025
The global molecular diagnostics market was valued at USD 8 billion in 2017 and is projected to grow at a CAGR of 7.1% during the period 2018 to 2025 to reach USD 13.87 billion by 2025.
Read More
06 Jul 2019
Global Surgical Imaging Market to Reach USD 1.49 Billion by 2026
The global surgical imaging market was estimated to be worth USD 1.06 billion in 2018 and is projected to grow at a CAGR of 4.3% during the period 2019–2026 to reach USD 1.49 billion by 2026.
Read More
Copyright © 2000-2019 TradeMed.com. All rights reserved. | Terms And Conditions